TD Asset Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Sell |
|
|||||
|
2025
Q1 | $12.8M | Buy |
|
|||||
|
2024
Q4 | $12.1M | Sell |
|
|||||
|
2024
Q3 | $18.4M | Sell |
|
|||||
|
2024
Q2 | $21M | Buy |
|
|||||
|
2024
Q1 | $5.44M | Sell |
|
|||||
|
2023
Q4 | $2.42M | Hold |
|
|||||
|
2023
Q3 | $1.71M | Buy |
|
|||||
|
2023
Q2 | $1.48M | Sell |
|
|||||
|
2023
Q1 | $2.34M | Sell |
|
|||||
|
2022
Q4 | $3.65M | Buy |
|
|||||
|
2022
Q3 | $2.23M | Buy |
|
|||||
|
2022
Q2 | $1.93M | Sell |
|
|||||
|
2022
Q1 | $2.64M | Sell |
|
|||||
|
2021
Q4 | $3.53M | Buy |
|
|||||
|
2021
Q3 | $2.55M | Buy |
|
|||||
|
2021
Q2 | $540K | Hold |
|
|||||
|
2021
Q1 | $610K | Buy |
|
|||||
|
2020
Q4 | $592K | Buy |
|
|||||
|
2020
Q3 | $608K | Buy |
|
|||||
|
2020
Q2 | $574K | Buy |
|